[
    [
        {
            "time": "",
            "original_text": "摩根大通增持药明康德(02359)约93.38万股，每股作价约181.11港元",
            "features": {
                "keywords": [
                    "摩根大通",
                    "增持",
                    "药明康德",
                    "港股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "摩根大通增持药明康德(02359)约93.38万股，每股作价约181.11港元",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "【行情】港股医药股终止连日涨势，复星医药跌3.9%，康龙化成跌3.6%，药明生物跌2.6%，药明康德跌2.2%，君实生物跌1.5%",
            "features": {
                "keywords": [
                    "港股",
                    "医药股",
                    "下跌",
                    "复星医药",
                    "康龙化成",
                    "药明生物",
                    "药明康德",
                    "君实生物"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【行情】港股医药股终止连日涨势，复星医药跌3.9%，康龙化成跌3.6%，药明生物跌2.6%，药明康德跌2.2%，君实生物跌1.5%",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "2020年CDMO领域收入排行，五年内“药明生物”市占率必降 盈利能力下降",
            "features": {
                "keywords": [
                    "CDMO",
                    "药明生物",
                    "市占率",
                    "盈利能力",
                    "下降"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "2020年CDMO领域收入排行，五年内“药明生物”市占率必降 盈利能力下降",
                "Correlation": 8,
                "Sentiment": 2,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "下一个“药明康德”来了？",
            "features": {
                "keywords": [
                    "药明康德"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "下一个“药明康德”来了？",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "1300亿美元怎么分？比尔·盖茨宣布与妻子离婚！5月券商金股出炉，4股业绩翻倍获机构扎堆推荐",
            "features": {
                "keywords": [
                    "比尔·盖茨",
                    "离婚",
                    "券商金股",
                    "业绩翻倍",
                    "机构推荐"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "1300亿美元怎么分？比尔·盖茨宣布与妻子离婚！5月券商金股出炉，4股业绩翻倍获机构扎堆推荐",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 2,
                "Duration": 2,
                "Entity_Density": 1,
                "Market_Scope": 2,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]